Ovarian stimulation (PDF, 135.73 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
RADIOIODINE THERAPY FOR HYPERTHYROIDISM, 400-600 MBq (PDF, 270.06 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
RADIOIODINE THERAPY FOR HYPERTHYROIDISM, 600-800 MBq (PDF, 271.44 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
RADIOIODINE THERAPY FOR HYPERTHYROIDISM, under 400 MBq (PDF, 180.95 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
Rituximab, MABTHERA®, RITEMVIA®, RIXATHON® – in treatment of rheumatic diseases (PDF, 212.7 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Sarilumab, KEVZARA® – in treatment of rheumatic diseases (PDF, 208.24 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Secukinumab, COSENTYX ® – in treatment of rheumatic diseases (PDF, 210.74 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Smoking and reproduction (PDF, 211.36 KB) |
The Wellbeing Services County of Southwest Finland |
Swedish |
|
Sulfasalazine, SALAZOPYRIN EN® – in treatment of rheumatic diseases (PDF, 209.27 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Testing of the visual system in children VEP (PDF, 143.07 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
Tocilizumab, ROACTEMRA® – in treatment of rheumatic diseases (PDF, 210.29 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Tofacitinib, Xeljanz® – in treatment of rheumatic diseases (PDF, 209.85 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Tubal patency ultrasound (PDF, 355.38 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
Urinary stone removal by urologic endoscopy (PDF, 168.53 KB) |
The Wellbeing Services County of Southwest Finland |
Finnish Swedish |
|
Ustekinumab, STELARA ® – in treatment of rheumatic diseases (PDF, 208.18 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|